within Pharmacolibrary.Drugs.ATC.A;

model A06AH02
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.06,
    Cl             = 0.00026,
    adminDuration  = 600,
    adminMass      = 12 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.030199999999999998,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0025166666666666666,
    Tlag           = 10.020000000000001,            
    Vdp             = 0.0625,
    k12             = 27.4,
    k21             = 27.4
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A06AH02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Alvimopan is a peripherally acting µ-opioid receptor antagonist used to accelerate the recovery of bowel function after bowel resection surgery. The drug reduces opioid-induced gastrointestinal side effects. It is approved for short-term inpatient use in adults undergoing bowel resection surgery.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are reported for healthy adult subjects after a single oral dose.</p><h4>References</h4><ol><li><p>Curran, MP, et al., &amp; Perry, CM (2008). Alvimopan. <i>Drugs</i> 68(14) 2011–2019. DOI:<a href=\"https://doi.org/10.2165/00003495-200868140-00006\">10.2165/00003495-200868140-00006</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/18778122/\">https://pubmed.ncbi.nlm.nih.gov/18778122</a></p></li><li><p>Foss, JF, et al., &amp; Schmith, VD (2008). Pharmacokinetics of alvimopan and its metabolite in healthy volunteers and patients in postoperative ileus trials. <i>Clinical pharmacology and therapeutics</i> 83(5) 770–776. DOI:<a href=\"https://doi.org/10.1038/sj.clpt.6100292\">10.1038/sj.clpt.6100292</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/17653140/\">https://pubmed.ncbi.nlm.nih.gov/17653140</a></p></li><li><p>Leslie, JB (2005). Alvimopan for the management of postoperative ileus. <i>The Annals of pharmacotherapy</i> 39(9) 1502–1510. DOI:<a href=\"https://doi.org/10.1345/aph.1E615\">10.1345/aph.1E615</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/16076918/\">https://pubmed.ncbi.nlm.nih.gov/16076918</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A06AH02;
